Post by Hyloris Pharmaceuticals

Where others stop, we start. 💡 At Hyloris Pharmaceuticals, our mission is clear: reinvent existing medicines to address unmet patient needs worldwide. 🌎 Too many patients still don't have access to the right treatment - not because the science doesn't exist, but because the medicine hasn't been optimized for them yet. That's exactly where we come in. We reformulate. We repurpose. And, we even develop some smart new chemical entities 🔬 - always with one goal: delivering tangible therapeutic benefits to patients who need better options. Our portfolio of 30+ products is built on deep scientific expertise and a disciplined, capital-efficient development model. We primarily leverage the FDA's 505(b)(2) pathway, which lets us build on established safety data, shorten timelines, reduce costs, and get improved medicines to patients faster. We don't start from scratch. WE START FROM WHAT WORKS - AND MAKE IT BETTER. Explore who we are in our Annual Report 2025: https://lnkd.in/dyqmbRgi #Hyloris #Health #Pharma #ReinventingMedicines #ReformulatingMedicines #RepurposingMedicines #AddressingUnmetMedicalNeeds #Innovation #SpecialtyPharma #505b2